Whole-exome sequencing analysis identifies distinct mutational profile and novel prognostic biomarkers in primary gastrointestinal diffuse large B-cell lymphoma

2021 Update on Diffuse large B cell lymphoma: A review of current data and potential applications on risk stratification and management

(2021) Sandra Susanibar‐Adaniya et al.   AMERICAN JOURNAL OF HEMATOLOGY

Genomic Mutation Profile of Primary Gastrointestinal Diffuse Large B-Cell Lymphoma

(2021) Peifeng Li et al.   Frontiers in Oncology

A global, regional, and national survey on burden and Quality of Care Index (QCI) of hematologic malignancies; global burden of disease systematic analysis 1990–2017

(2021) Mohammad Keykhaei et al.   Experimental Hematology & Oncology

Tumor mutation burden estimated by a 69-gene-panel is associated with overall survival in patients with diffuse large B-cell lymphoma

(2021) Cunte Chen et al.   Experimental Hematology & Oncology

LRP1B: A Giant Lost in Cancer Translation

(2021) Catarina Príncipe et al.   Pharmaceuticals

Whole exome sequencing reveals a novel LRBA mutation and clonal hematopoiesis in a common variable immunodeficiency patient presented with hemophagocytic lymphohistiocytosis

(2021) Yanling Ren et al.   Experimental Hematology & Oncology

The repertoire of mutational signatures in human cancer

(2020) Ludmil B. Alexandrov et al.   NATURE

Oncogenic Mutations of MYD88 and CD79B in Diffuse Large B-Cell Lymphoma and Implications for Clinical Practice

(2020) Carlo Visco et al.   Cancers

S-Geranylgeranyl-l-glutathione is a ligand for human B cell-confinement receptor P2RY8

(2019) Erick Lu et al.   NATURE

Association of LRP1B Mutation With Tumor Mutation Burden and Outcomes in Melanoma and Non-small Cell Lung Cancer Patients Treated With Immune Check-Point Blockades

(2019) Hao Chen et al.   Frontiers in Immunology

Pathogenic B‐cell receptor signaling in lymphoid malignancies: New insights to improve treatment

(2019) Ryan M. Young et al.   IMMUNOLOGICAL REVIEWS

Gastrointestinal non-Hodgkin lymphomas

(2019) Magdalena Olszewska-Szopa et al.   Advances in Clinical and Experimental Medicine

Incidence and Mortality Trends and Risk Prediction Nomogram for Extranodal Diffuse Large B-Cell Lymphoma: An Analysis of the Surveillance, Epidemiology, and End Results Database

(2019) Xuejiao Yin et al.   Frontiers in Oncology

Genetic landscape of hepatitis B virus–associated diffuse large B-cell lymphoma

(2018) Weicheng Ren et al.   BLOOD

Extranodal Diffuse Large B Cell Lymphoma: Molecular Features, Prognosis, and Risk of Central Nervous System Recurrence

(2018) Thomas A. Ollila et al.   CURRENT TREATMENT OPTIONS IN ONCOLOGY

Genetics and Pathogenesis of Diffuse Large B-Cell Lymphoma

(2018) Roland Schmitz et al.   NEW ENGLAND JOURNAL OF MEDICINE

Targeted next generation sequencing reveals high mutation frequency of CREBBP, BCL2 and KMT2D in high-grade B-cell lymphoma with MYC and BCL2 and /or BCL6 rearrangements

(2018) Solène M Evrard et al.   HAEMATOLOGICA

Mutational frequencies of CD79B and MYD88 vary greatly between primary testicular DLBCL and gastrointestinal DLBCL

(2017) Mareike Frick et al.   LEUKEMIA & LYMPHOMA

MYD88 L265P Mutations, But No Other Variants, Identify a Subpopulation of DLBCL Patients of Activated B-cell Origin, Extranodal Involvement, and Poor Outcome

(2016) J. Rovira et al.   CLINICAL CANCER RESEARCH

Impact of the double expression of MYC and BCL2 on outcomes of localized primary gastric diffuse large B-cell lymphoma patients in the rituximab era

(2016) A Kawajiri et al.   Blood Cancer Journal

LRP1B deletion is associated with poor outcome for glioblastoma patients

(2015) E. Tabouret et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Whole-genome sequencing reveals activation-induced cytidine deaminase signatures during indolent chronic lymphocytic leukaemia evolution

(2015) S. Kasar et al.   Nature Communications

Hepatitis B virus-associated diffuse large B-cell lymphoma: unique clinical features, poor outcome, and hepatitis B surface antigen-driven origin

(2015) Lijuan Deng et al.   Oncotarget

Exome sequencing reveals novel mutation targets in diffuse large B-cell lymphomas derived from Chinese patients

(2014) N. F. C. C. de Miranda et al.   BLOOD

Down expression ofLRP1Bpromotes cell migration via RhoA/Cdc42 pathway and actin cytoskeleton remodeling in renal cell cancer

(2013) Shaobin Ni et al.   CANCER SCIENCE

High prevalence of oncogenic MYD88 and CD79B mutations in primary testicular diffuse large B-cell lymphoma

(2013) W Kraan et al.   LEUKEMIA

Mutational landscape and significance across 12 major cancer types

(2013) Cyriac Kandoth et al.   NATURE

Cancer Genome Landscapes

(2013) B. Vogelstein et al.   SCIENCE

Comprehensive identification of mutational cancer driver genes across 12 tumor types

(2013) David Tamborero et al.   Scientific Reports

Distribution of Lymphoid Neoplasms in China

(2012) Jian Sun et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Recurrent Targeted Genes of Hepatitis B Virus in the Liver Cancer Genomes Identified by a Next-Generation Sequencing–Based Approach

(2012) Dong Ding et al.   PLoS Genetics

Chromosomal, epigenetic and microRNA-mediated inactivation of LRP1B, a modulator of the extracellular environment of thyroid cancer cells

(2010) H Prazeres et al.   ONCOGENE

MYC gene rearrangements are associated with a poor prognosis in diffuse large B-cell lymphoma patients treated with R-CHOP chemotherapy

(2009) K. J. Savage et al.   BLOOD

High prevalence of occult hepatitis B virus infection in patients with B cell non-Hodgkin’s lymphoma

(2008) Ming-Huang Chen et al.   ANNALS OF HEMATOLOGY